{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/breast-cancer-managing-fh/how-this-topic-was-developed/organizational-behavioural-financial-barriers/","result":{"pageContext":{"chapter":{"id":"0bfaeb6f-e800-5a87-a861-0d00aeb7c136","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers","depth":2,"htmlHeader":"<!-- begin field 0805052f-0738-4e57-9b9d-a7f3000c75e8 --><h2>Organizational, behavioural and financial barriers</h2><!-- end field 0805052f-0738-4e57-9b9d-a7f3000c75e8 -->","summary":null,"htmlStringContent":"<!-- begin item e28e9abf-5b21-487b-8b7e-a7f3000c45d5 --><!-- begin field e72fa48c-155d-4423-b27a-a7f3000c75e8 --><h2>Our policy</h2><!-- end field e72fa48c-155d-4423-b27a-a7f3000c75e8 --><!-- begin field 580d3e11-4ea3-4de0-b641-a7f3000c75e8 --><p>The CKS literature searches take into consideration the following concepts, which are discussed at the initial scoping of the topic.</p><ul><li>Feasibility<ul><li>Studies are selected depending on whether the intervention under investigation is available in the NHS and can be practically and safely undertaken in primary care.</li></ul></li><li>Organizational and Financial Impact Analysis</li><li>Studies are selected and evaluated on whether the intervention under investigations may have an impact on local clinical service provision or national impact on cost for the NHS. The principles of clinical budget impact analysis are adhered to, evaluated and recorded by the author. The following factors are considered when making this assessment and analysis.<ul><li>Eligible population</li><li>Current interventions</li><li>Likely uptake of new intervention or recommendation</li><li>Cost of the current or new intervention mix</li><li>Impact on other costs</li><li>Condition-related costs</li><li>In-direct costs and service impacts</li><li>Time dependencies</li></ul></li><li>Cost-effectiveness or cost-benefit analysis studies are identified where available. </li></ul><p>We also evaluate and include evidence from NICE accredited sources which provide economic evaluations of recommendations, such as NICE guidelines. When a recommended action may not be possible because of resource constraints, this is explicitly indicated to healthcare professionals by the wording of the CKS recommendation.</p><!-- end field 580d3e11-4ea3-4de0-b641-a7f3000c75e8 --><!-- end item e28e9abf-5b21-487b-8b7e-a7f3000c45d5 -->","topic":{"id":"273ad47e-ae65-5768-be53-5ddd1a59479e","topicId":"bd5ef0a7-5bdf-453b-919f-23ebeade59e8","topicName":"Breast cancer - managing FH","slug":"breast-cancer-managing-fh","lastRevised":"Last revised in December 2018","chapters":[{"id":"f6ca27fc-9049-5932-b6b5-c6a1a14a77fd","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"2dd4a7a9-b879-5145-a15c-5922ac8e62ed","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"1eedf81f-6c36-5c24-816f-0c373b4fe0f4","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"f7449f3e-937f-584a-90af-48470e794a2c","slug":"changes","fullItemName":"Changes"},{"id":"28bea84b-3026-59d1-a564-3b8f8e660f19","slug":"update","fullItemName":"Update"}]},{"id":"d2268871-af9e-569e-ae6e-a786ab1bacec","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"c2ad0bbf-95fa-5512-a763-618d653b1f5e","slug":"goals","fullItemName":"Goals"},{"id":"b4ec1615-f118-573f-a98d-d4bbfdf7d53d","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"467c7316-a736-5600-b8e5-1c4ebf44b7ce","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"34c8a1ea-20f5-5197-86ff-6e75ed2a01c5","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"3361517e-9866-5a17-aabf-4d923a96c917","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"fdcd7c54-3a68-5903-a4a1-241a63d19e62","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"d7bd1803-d45e-508d-8661-62ebaa4b3353","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"c6831679-919f-5e59-b6b9-d09ed6486aca","slug":"definition","fullItemName":"Definition"},{"id":"7d6fa54b-1dc8-5cbd-9bf4-6d9ac0dc26f0","slug":"prevalence","fullItemName":"Prevalence"},{"id":"c5d1b518-b87d-58d6-8554-f3960af8f976","slug":"genetic-risk-factors","fullItemName":"Genetic risk factors"}]},{"id":"61970169-7827-5d9e-acb0-e40e0888525d","fullItemName":"Management","slug":"management","subChapters":[{"id":"b118c829-c5a1-5ee5-a8da-71eb67facd8d","slug":"breast-cancer-managing-fh","fullItemName":"Scenario: Breast cancer - managing FH"}]},{"id":"eaf7a93e-8dae-5737-ba9c-13e8ad484b3c","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"a9d84940-3c17-5039-b3f8-73ef73f06d13","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"a8dea3b7-f328-50ea-985f-2d54f906032c","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"067fe34b-66c2-52be-b2a6-f9366eaa8c2e","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"1f91e5ff-a2aa-5aaf-ac5c-67750822d1e8","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"0bfaeb6f-e800-5a87-a861-0d00aeb7c136","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"773a3929-781a-5faf-8d55-166112725d3a","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"89bfc412-56d8-52c5-95b1-6e923396679a","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"a9d84940-3c17-5039-b3f8-73ef73f06d13","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}